SCHEMBL6645846

SCHEMBL6645846

COC(=O)c1ccc(CN(Cc2ccccn2)C(=O)OC(C)(C)C)c2ccccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.40
KDM4E B2RXH2 5/20 0.40
MAPT P10636 4/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
NPSR1 Q6W5P4 3/20 0.40
HSD17B10 Q99714 2/20 0.40
ALOX15 P16050 1/20 0.40
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37
TRPM8 Q7Z2W7 1/20 0.37
CYP1A2 P05177 1/20 0.37
HTT P42858 2/20 0.36
TSHR P16473 2/20 0.36
HPGD P15428 1/20 0.36
MAPK1 P28482 1/20 0.36
MAP2K1 Q02750 1/20 0.36
HDAC3 O15379 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35
NCOR2 Q9Y618 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6018246 0.91 KDM4E (0.47) ALDH1A1KDM4EMAPTSMN1; SMN2NPSR1
SCHEMBL6018238 0.90 KDM4E (0.40) ALDH1A1KDM4EMAPTSMN1; SMN2NPSR1
SCHEMBL6018095 0.82 LMNA (0.38) KDM4EMAPTLMNAHDAC3HDAC1
SCHEMBL6018169 0.81 KDM4E (0.42) ALDH1A1KDM4EMAPTSMN1; SMN2NPSR1
SCHEMBL3107925 0.79 MAPK8 (0.39) ALDH1A1KDM4EMAPTSMN1; SMN2HSD17B10
SCHEMBL4939432 0.79 HDAC3 (0.51) ALDH1A1KDM4EMAPTSMN1; SMN2NPSR1
SCHEMBL6017972 0.79 HDAC3 (0.41) ALDH1A1KDM4EMAPTSMN1; SMN2NPSR1
SCHEMBL6017846 0.77 KDM4E (0.39) ALDH1A1KDM4EMAPTSMN1; SMN2NPSR1
SCHEMBL27439189 0.76 TRPM8 (0.55) KDM4EMAPTSMN1; SMN2NPSR1TRPM8
SCHEMBL6018297 0.74 HDAC3 (0.46) ALDH1A1KDM4EMAPTSMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040157818-A1 Cxcr4-antagonistic drugs composed of nitrogen-containing compound KUREHA CORPORATION (JP) 2004-08-12 US disclosed
EP-1389460-A1 CXCR4-ANTAGONISTIC DRUGS COMPRISING NITROGEN-CONTAINING COMPOUND Kureha Chemical Industry Co., Ltd. (JP) 2004-02-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157818-A1 Cxcr4-antagonistic drugs composed of nitrogen-containing compound CXCR4, CXCR1, CXCR2 ALDH1A1 2237/4885KDM4E 4175/4885MAPT 4667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.